Skip to main content
Figure 2 | BMC Immunology

Figure 2

From: VACUTAINER® CPT™ and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples

Figure 2

Viability of CPT-processed PBMC is not adversely affected by cryopreservation. The viability (percent of live cells) of fresh and cryopreserved PBMC was compared based on processing method. Significant difference (p) was determined by the Wilcoxon signed rank test. Each filled circle represents an individual donor and each donor is represented by the same color for each of the conditions tested. The "+" represents the median of all the donors in the category.

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us